Aberrant expression of SFRP1 and β-catenin plays important roles in the development of a range of cancers, such as biliary tract cancer, mucoepidermoid carcinoma, adrenocortical tumors and cervical cancer [16,37–39]. This evidence concerns the gene SFRP1 and mucoepidermoid carcinoma.